HBV Mutation Detail Information

> L180M Search Result


Mutation Information
Mutation Site L180M
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Combined Mutation rt.L180M+rt.M204V
Relevant Drug lamivudine (LAM)
Country Cameroon
Literature Information
PubMed PMID 26419862
Disease HBV-HIV coinfection
Published Year 2016
Journal Current HIV research
Title High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians.
Author Salpini R,Fokam J,Ceccarelli L,Santoro MM,Nanfack A,Sosso SM,Kowo M,Cento V,Torimiro J,Sarmati L,Andreoni M,Colizzi V,Perno CF,Njoya O
Evidence One out of four 3TC-treated participants (25%) analyzed for drug resistance mutations harbored M204V+L180M, associated with HBV resistance to 3TC. RT resistance was not detected among anti-HBV drug-naïve participants.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation